N@N

Matthew Harrison Maintained (AMGN) at Buy with Increased Target to $276 on, Dec 16th, 2020

Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $275 to $276 on, Dec 16th, 2020.

Matthew has made no other calls on AMGN in the last 4 months.

There are 11 other peers that have a rating on AMGN. Out of the 11 peers that are also analyzing AMGN, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Geoffrey Porges of "SVB Leerink" Maintained at Hold with Increased Target to $253 on, Wednesday, December 9th, 2020
• Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $215 on, Monday, November 2nd, 2020
• Colin Bristow of "UBS" Initiated at Hold and Held Target at $232 on, Wednesday, October 28th, 2020
• Robyn Karnauskas of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $251 on, Monday, October 12th, 2020
• Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, October 9th, 2020

These are the ratings of the 6 analyists that currently disagree with Matthew

---

• Ian Somaiya of "BMO Capital" Maintained at Buy with Decreased Target to $304 on, Thursday, October 29th, 2020
• Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $265 on, Thursday, October 29th, 2020
• Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Decreased Target to $278 on, Thursday, October 29th, 2020
• Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $284 on, Tuesday, October 27th, 2020
• Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $255 on, Monday, October 26th, 2020
• Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $280 on, Tuesday, October 6th, 2020

Contributing Sources

---